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ABSTrACT
This is a case-control study conducted with diabetic patients in Kinta, Kampar and Larut-Matang-Selama districts of 
Perak, Malaysia. We intended to determine the factors contributing to the development of active tuberculosis among 
diabetes patients. Cases were culture-proven and registered in the Malaysian National Tuberculosis Surveillance 
Registry (MyTB) from 2012 to 2018. Controls were diabetes patients identified from the National Diabetes Registry and 
were matched with cases based on the clinic in which they were registered at a ratio of 1:1. 119 cases and 119 controls 
were included in this study. Multivariate analysis was used to identify clinical factors associated with tuberculosis. 
Patient had increased odds of having tuberculosis if they had higher glycaemic (HbA1c) levels (OR=1.41, 95% CI 
0.22-0.96, p<0.001) or nephropathy (OR=8.91, 95% CI 2.31-34.05, p<0.001). The odds ratio was lower if they have 
diabetes for at or more than 5 years (OR=0.46, 95% CI 0.22-0.96, p=0.04) and older (OR=0.96, CI 0.92-0.99, p=0.02). 
In conclusion, this study suggests that routine screening for tuberculosis in patients with diabetes should consider the 
diabetic duration, glycemic control, presence of nephropathy, and age of the patient. 
Keywords: Case-control study; diabetic associated factors; diabetic nephropathy; type 2 diabetes mellitus; tuberculosis
ABSTrAK
Ini adalah sebuah kajian kes kawalan yang melibatkan pesakit diabetes di daerah Kinta, Kampar dan Larut-Matang-
Selama Perak, Malaysia. Kajian ini bertujuan untuk menentukan faktor yang menyumbang kepada perkembangan 
tuberkulosis aktif dalam kalangan pesakit diabetes. Kes bermaksud pesakit yang terbukti mendapat jangkitan 
tuberkulosis melalui kultur yang didaftarkan di Sistem Maklumat Tuberkulosis Kebangsaan (MyTB) dari tahun 2012 
hingga 2018. Kawalan adalah pesakit diabetes yang dikenal pasti daripada Sistem Maklumat Diabetes Kebangsaan dan 
dipadankan dengan kes berdasarkan klinik dengan pesakit-pesakit tersebut didaftarkan dan dalam nisbah 1: 1. Kajian 
ini melibatkan 119 kes dan 119 kawalan. Analisis multivariat digunakan untuk mengenal pasti faktor klinikal yang 
berkaitan dengan tuberkulosis. Pesakit berisiko untuk tuberkulosis jika mereka mempunyai tahap glisemik (HbA1c) 
yang tinggi (OR=1.41, 95% CI 0.22-0.96, p<0.001) atau masalah ginjal (OR=8.91, 95% CI 2.31-34.05, p<0.001). 
Kebarangkalian pesakit untuk mendapat tuberkulosis berkurangan sekiranya mereka mempunyai diabetes 5 tahun atau 
lebih (OR=0.46, 95% CI 0.22-0.96, p=0.04) dan berumur (OR=0.96, CI 0.92-0.99, p=0.02). Kesimpulannya, kajian 
ini menunjukkan bahawa pemeriksaan rutin tuberkulosis pada pesakit diabetes harus mempertimbangkan tempoh 
diabetes, kawalan glisemik, keadaan ginjal dan usia pesakit.
Kata kunci: Diabetes; faktor berkaitan diabetes; kajian kes kawalan; masalah ginjal;  tuberkulosis
InTroDuCTIon
Tuberculosis has affected humans for thousands of 
years and has a long history (Daniel 2006). It remains 
a threat, surpassing human immunodeficiency virus 
(hIV) as the leading cause of death worldwide from 
infectious diseases (World health organization 2018). 
Tuberculosis is an airborne infectious disease caused by 
Mycobacterium tuberculosis. Despite strong efforts in 
the past decade towards controlling tuberculosis-related 
morbidity and mortality, there were as many as 10.0 million 
new tuberculosis cases and 1.3 million deaths worldwide 
reported in 2017 (World health organization 2018). 
Malaysia is considered a high tuberculosis burden country, 
with an estimated incidence of 93 cases per 100,000 
population (World health organization 2019). In 2016, 
25,005 were cases reported, and the number continues to 
rise (World health organization 2019).
Studies have shown that diabetes mellitus increases 
the risk of active tuberculosis three-fold, which 
complicates efforts to curb the pandemic (Leung et al. 
2008). The World health organization estimated that 
up to 15% of tuberculosis globally is related to diabetes 
mellitus, and its prevalence is expected to rise in developed 
1082 
and developing countries (World health organization 
2011). The national health and Morbidity Survey 2015 
showed that the prevalence of diabetes in Malaysia has 
increased from 15.2% in 2011 to 17.5% in 2015, meaning 
that about 3.5 million Malaysian people above 18 years 
old have diabetes (Institute for Public health 2015). 
There were over 3,492,600 cases of diabetes reported 
among adults in 2017 (International Diabetes Federation 
2019). The dual epidemics of tuberculosis and diabetes 
in Malaysia are expected to cause a surge in tuberculosis 
cases; thus, implementing a cost-effective screening 
program is vital to control the pandemic. 
It is well known that diabetes increases the risk of 
tuberculosis, but the risk increases differently in low and 
high tuberculosis burden countries. Two cohort studies 
in Australia and China reported that people with diabetes 
had 1.5 to 3 times higher risk of developing tuberculosis 
compared to people without diabetes (Dobler et al. 2012; 
Wang et al. 2013). A cross-sectional study in Taiwan and 
a retrospective population-based study in China reported 
that the prevalence of diabetes among newly diagnosed 
patients with tuberculosis was as high as 27.9% and 19.9%, 
respectively (Ko et al. 2017; Wu et al. 2016). In Malaysia, 
the prevalence of tuberculosis in patients with diabetes 
ranges from 14% to 33% (Swarna nantha 2012).  
Diabetes increases the risk of tuberculosis, but not 
all diabetic patients develop active tuberculosis. Factors 
influencing the development of tuberculosis have been 
explored in several studies (Alkabab et al. 2015; Dobler 
et al. 2012; Dooley et al. 2009; Leung et al. 2008). There 
is evidence that poor glycaemic control increases the risk 
of contracting tuberculosis (Ko et al. 2017). A cohort 
study demonstrated that diabetic patients with hbA1c of 
more than 7% had 3 times the tuberculosis hazard risk 
(Leung et al. 2008). In the Middle east, about one in 
two diabetic patients with hbA1c of more than 8% have 
tuberculosis (Alkabab et al. 2015). In addition, a longer 
disease duration and the use of insulin were found to be 
associated with a higher chance of developing tuberculosis 
among diabetics (Alkabab et al. 2015; Dobler et al. 2012; 
Dooley & Chaisson 2009). 
To date, there is little agreement on screening for 
tuberculosis among people with diabetes worldwide and 
in Malaysia. The World health organization recommends 
symptom-based approach in which chest radiograph 
and sputum examination will be done in those with 
symptoms suggestive of tuberculosis (World health 
organization 2011). This has been practiced in many 
countries including China and India (Lin et al. 2015, India 
Tuberculosis-Diabetes Study group 2013). In addition, 
the World health organization recommends systematic 
screening for tuberculosis among diabetic patients from 
countries with high prevalence of tuberculosis (World 
health organization 2011). Thus, the Ministry of health 
Malaysia recommends systematic approach using chest 
radiograph, tuberculin skin test or Interferon gamma 
release Assay in asymptomatic high-risk individuals 
including diabetics (MahTAS 2012). In 2015, the national 
data showed that among 340,000 diabetes patients 
screened for tuberculosis, 32% were screened using 
chest radiograph and the remaining tests were based on 
symptoms. however, the yield was low, with only 742 or 
0.22% positive for tuberculosis (Disease Control Division 
2016). A similar pattern was seen in Perak in the same 
year, as out of 25,454 chest radiographs performed among 
diabetics, only 74 or 0.29% were diagnosed with active 
tuberculosis (Perak State health Department 2015). 
Debate continues about the best strategies to screen 
for tuberculosis among diabetic patients as the yield was 
low either using the chest radiograph and symptoms 
based or chest radiograph alone as seen in the national 
and Perak data. More importantly, studies on factors that 
increase the likelihood of tuberculosis among diabetics 
have been limited. Thus, the aim of this study was to 
identify factors associated with having active tuberculosis 
among diabetes patients in Perak. Specifically, this study 
examined the association between active tuberculosis and 
clinical factors like glycaemic control, disease duration, 
insulin use, and diabetic complications. By identifying 
these factors, this study hopes to be able to suggest a 
more targeted group of diabetic patients to be screened 
for tuberculosis. 
MATerIALS AnD MeThoDS
STuDY SeTTIng
This was a case-control study involving type 2 diabetic 
patients registered under 16 government health clinics 
in the districts of Kinta, Kampar, and Larut-Matang-
Selama in Perak. The patients were identified through 
the national Tuberculosis International System (MyTB) 
and the national Diabetes registry. MyTB is a registry 
for new tuberculosis cases detected in Malaysia and 
contains data on socio-demographic characteristics, type 
of tuberculosis, direct smear, culture and sensitivity, 
treatment, and outcomes. The tuberculosis data are 
captured manually on medical cards and a medical 
assistant then updates it in the registry upon diagnosis 
and every two months until each patient has completed 
treatment. The national Diabetes registry monitors the 
quality of care received by diabetic patients and has data 
on socio-demographic characteristics, co-morbidities, 
treatment regimens, and diabetic complications. Similar 
to tuberculosis, the diabetes data are recorded manually 
on  medical cards and a medical assistant would updates 
the registry at six-monthly intervals. 
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STuDY PoPuLATIon
CASe DeFInITIon AnD SAMPLIng
The cases were Malaysians aged 18 years and above, 
diagnosed with type 2 diabetes mellitus and culture-
confirmed tuberculosis. A total of 287 patients with 
culture-confirmed tuberculosis diagnosed from 2012 to 
2018 in the MyTB registry were identified. Patients 
with immune suppression (e.g. hIV) were excluded 
from this study. From this sampling frame, every second 
patient was systematically selected for inclusion. 
ConTroL DeFInITIon AnD SAMPLIng
Controls were Malaysians aged 18 years and above, 
with type 2 diabetes mellitus but without tuberculosis. 
From the national Diabetes registry, 1190 patients 
were registered during the same period and from this 
sampling frame, every tenth patient was systematically 
sampled for inclusion. The ratio for cases and controls 
was 1 to 1 and matched based on the health clinic at 
which they were registered. 
SAMPLe SIze
This sample size was calculated based on the assumption 
that 70% of the diabetic population has poor glycaemic 
control with elevated hbA1c level of more than 6.5%, 
and the odds of them to have tuberculosis was 3 times 
higher compared to diabetics with good glycaemic 
control (Chew et al. 2011; Dooley & Chaisson 2009). 
using a sample size calculator for case-control studies 
with study power of 90%, significance level of 5%, and 
the ratio for cases to controls was 1:1. The minimum 
number of samples required for cases and controls was 
112.
STuDY VArIABLeS AnD DATA CoLLeCTIon
The presence of tuberculosis in the cases was defined 
as culture-confirmed tuberculosis. The duration of 
diabetes was calculated by subtracting the year of 
diagnosis from 2018, the year of data collection. 
The diabetic complications documented included 
retinopathy, proteinuria, nephropathy (defined as serum 
creatinine >106 mmol/L), ischemic heart disease and 
cerebrovascular disease (stroke). Treatment regime was 
defined as treatment with oral anti-diabetics only or with 
insulin. As for the demographic data, age was calculated 
from the date of birth and documented in years, sex 
as female or male and ethnicity as Malay, Chinese or 
Indian. This information was extracted from the national 
Diabetes registry. In the event of incomplete information 
from the registry, the researcher obtained the required 
information from the patient’s diabetic cards, obtained 
from their respective clinic. The hbA1c value for cases 
was at diagnosis of TB, while the hbA1c value for 
controls was the latest available value.
STATISTICAL AnALYSIS
Data management and analysis were performed using 
IBM SPSS Version 23.0® (Armonk, nY: IBM Corp). 
Continuous data were summarized as means and 
standard deviations if normally distributed, or medians 
and interquartile ranges if otherwise. Categorical 
data were presented as frequencies with percentages. 
Demographic and clinical characteristics were 
compared between cases and controls, using the Chi-
square test for categorical variables and the independent 
samples t-test for continuous variables. Prior to statistical 
analysis, the treatment regimens were grouped into oral 
hypoglycaemic agent (ohA) and insulin use, if insulin 
was used either in combination with ohA or insulin 
alone. Multivariate logistic regression analysis was 
used to determine the association between tuberculosis 
and clinical factors such as duration of diabetes, hbA1c 
level, insulin use, and micro and macro complications, 
adjusting for socio-demographic factors. A P value of 
<0.05 was set as significant. 
eThICAL goVernAnCe
The study was approved by the Medical research and 
ethics Committee (MreC) of the Ministry of health 
Malaysia [(5) KKM/nIhSeC/P17-784) and by the 
universiti Kebangsaan Malaysia ethics committee 
(uKM FPr.4/244/FF-2017-323). The ethics committees 
waived the needs of obtaining individual patient consent 
as this study used secondary data. Master lists linking 
patients’ identification numbers and names were stored 
securely and not shared. no personal data or unique 
identifiers were recorded in the data collection forms. 
reSuLTS
The study included 238 patients, of which 119 were 
tuberculosis cases and 119 were controls. Table 1 
compares the demographic and clinical characteristics of 
cases and controls. The patients in cases appeared to be 
younger (56 ± SD 12.4 years) compared to the control 
group (62.9 ± SD 10.5 years). The mean hbA1c was 
higher (9.5 ± SD 2.5 %) in cases compared to controls 
(7.9 ± SD 1.93 %). The median duration of diabetes 
in cases (3 ± IQr 2-9 years) was 3 years shorter than 
controls (6 ± IQr 4-12 years). In terms of insulin usage, 
the proportion of patients on insulin was higher in cases 
(37.8%) compared to controls (28.5%). 
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TABLe 1. Clinical and demographic characteristics of cases and controls
Variable Cases (Type 2 Diabetics with TB)
(n=119)
Controls
(Type 2 Diabetics without TB)
(n=119)
p-value
Demographic characteristics
Age mean (SD) 56.0 (12.4) 62.7 (10.5) <0.001a
gender Male 82 (68.9) 60 (50.4)
Female 37 (31.1) 59 (49.6)
ethnicity Malay 72 (60.5) 50 (42.0)
Chinese 24 (20.2) 41 (34.5)
Indian 23 (19.3) 28 (23.5)
Clinical characteristics
Duration of diabetes (years) <5 62 (52.1) 42 (35.3) 0.009b
≥5 57 (47.9) 77 (64.7)
hbA1c, mean (SD)** 9.5 (2.5) 7.9 (1.93) <0.001a
Treatment
Metformin use Yes 97 (81.5) 103 (86.6) 0.29b
no 22 (18.5) 16 (13.4)
Sulphonylurea use Yes 73 (61.3) 63 (52.9) 0.19b
no 46 (38.7) 56 (47.1)
Insulin use Yes 45 (37.8) 34 (28.6) 0.13b
no 74 (62.2) 85 (71.4)
Microvascular complications
Proteinuria*** Positive 40 (41.7) 32 (33.0) 0.21b
negative 56 (58.3) 65 (67.0)
nephropathy Yes 18 (15.1) 7 (5.9) 0.02b
no 101 (84.9) 112 (94.1)
retinopathy Yes 7 (5.9) 8 (6.7) 0.79b
no 112 (94.1) 111 (93.3)
Macrovascular complications
Ischaemic heart disease Yes 12 (10.1) 7 (5.9) 0.23b
no 107 (89.9) 112 (94.1)
Cerebrovascular disease Yes 2 (1.7) 2 (1.7) 1.00c
no 117 (98.3) 117 (98.3)
*Data shown are frequencies (column percentages) unless otherwise indicated. ** Missing data for hbA1c, n=7 for Cases and n=1 for Controls. *** Missing data for 
Proteinuria, n=23 for Cases and n=22 for Controls
aIndependent t-test. bPearson’s Chi-squared test. c Fisher exact Test
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Table 2 shows the associations between clinical 
factors (duration of diabetes, level of hbA1c, insulin use, 
proteinuria, nephropathy, retinopathy, ischaemic heart 
disease, and cerebrovascular disease) and tuberculosis. 
Simple logistic regression analysis was used for each 
variable to get the crude odds ratio. The duration of 
diabetes, hbA1c level and presence of nephropathy were 
statistically significant from this analysis. Subsequently, 
each variable was adjusted for socio-demographic 
characteristics including age, gender, and ethnicity using 
multiple logistic regression analysis. Those with diabetes 
for five or more years had a 50% risk reduction (or=0.50, 
95% CI 0.30-0.84, p=0.01) compared to those with a 
shorter duration of diabetes. After adjustment for socio-
demographic characteristics, the risk to have tuberculosis 
in diabetics with the duration of diabetes at or more than 
5 years was reduced to 43% (or=0.57, 95% CI 0.32-1.00, 
p=0.05). For each percentage increment in hbA1c, the 
odds ratio of developing tuberculosis increased by 1.4 
times (or=1.39, 95% CI 1.22-1.58, p<0.001) and after 
adjusted for socio-demographic variables it remained 
almost similar (or=1.34, 95% CI 1.17-1.55, p<0.001). 
There were no increased odds of tuberculosis associated 
with insulin use, before (or=1.52, 95% CI 0.88-2.62, 
p=0.13) and after adjusting for socio-demographic 
characteristics (or=1.71, 95% CI 0.94-3.14, p=0.07). 
Patients with nephropathy had almost 3 times higher odds 
(or=2.85, 95% CI 1.14-7.11, p=0.03) of developing active 
tuberculosis compared to those without nephropathy and 
the odds increased to 5.5 times after adjusted for socio-
demographic characteristics (or=5.55, 95% CI 1.98-
15.59, p <0.001).
TABLe 2. Crude and adjusted odds ratios of tuberculosis among diabetic patients
                                  univariate analysis                                                              Multivariate analysis#
Variable B S.e. Wald unadjusted or
(95% CI)
p-value B S.e. Wald Adjusted-or 
(95%CI)
p-value
Diabetes ≥ 5 years 
[Diabetes < 5 years]
-0.69 0.27 6.76 0.50(0.30,0.84) 0.01 -0.56 0.29 3.81 0.57 (0.32, 1.00) 0.05
hbA1c level 0.33 0.07 25.37 1.39 (1.22, 1.58) <0.001 0.29 0.07 17.30 1.34 (1.17, 1.55) <0.001
Insulin use [no] 0.42 0.28 2.28 1.52 (0.88, 2.62) 0.13 0.56 0.31 3.40 1.71 (0.94, 3.14) 0.07
retinopathy [no] -0.14 0.54 0.07 0.87 (0.30,2.47) 0.96 -0.12 0.59 0.04 0.89 (0.28, 2.84) 0.84
Proteinuria [no] 0.37 0.30 1.55 1.45(0.81,2.61) 0.21 0.40 0.33 1.48 1.49(0.79,2.81) 0.22
nephropathy [no] 1.05 0.47 5.05 2.85 (1.14, 7.11) 0.03 1.71 0.53 10.59 5.55 (1.98, 15.59) <0.001
Ischaemic heart 
disease [no]
0.59 0.49 1.40 1.79(0.68, 4.73) 0.24 0.73 0.54 1.82 2.07 (0.72, 6.00) 0.18
Cerebrovascular 
disease [no]
0.00 1.01 0.00 1.00 (0.14, 7.22) 1.00 0.17 1.08 0.03 1.19 (0.14, 9.86) 0.88
#Multivariate analysis: adjusted for socio-demographic characteristics: age, gender, and ethnicity. 
[-] reference group
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Subsequently, a multiple logistic regression analysis was 
conducted in which all the clinical and sociodemographic 
variables were analysed at once using the enter method 
(Table 3). Patients diagnosed with diabetes for less 
than 5 years, those with higher hbA1c and those with 
nephropathy had increased odds of having contracted 
tuberculosis. In this analysis, diabetic duration of at or 
more than five years was related to a 54% reduction in 
tuberculosis risk (or=0.46, 95% CI 0.22-0.96, p=0.04). 
The hbA1c level has consistently been associated with 
higher odds of developing active tuberculosis, and 
the risk was 1.4 times higher than those with a lower 
hbA1c level (or=1.41,95% CI 1.16,1.72, p<0.001). The 
association between tuberculosis and nephropathy was 
further strengthened through this analysis. The odds for 
active tuberculosis were almost 9 times higher (or=8.91, 
95% CI 2.31, 34.05, p<0.001) than those for patients 
without nephropathy. Age was significantly associated 
with tuberculosis. With increasing age, tuberculosis risk 
was reduced by 4% each year (or=0.96, 95% CI 0.92, 
0.99, p=0.02). 
DISCuSSIon
This study aimed to identify factors which increase the 
likelihood of TB among diabetic patients, in order to 
allow for better-targeted screening. generally, there is 
no standardized definition for long-standing diabetes 
mellitus due to the difficulties to determine the exact 
duration of the disease since its onset. A duration of 5 
years or more from the diagnosis of diabetes is considered 
TABLe 3. Factors associated with tuberculosis among diabetic patients 
Variable B S.e. Wald Adjusted
or (95% CI)
p-value
Age -0.04 0.18 5.74 0.96 (0.92,0.99) 0.02
gender
Male [Female] 0.43 0.38 1.26 1.53 (0.73,3.23) 0.39
ethnicity
Malay [Chinese] 0.09 0.42 0.05 1.09(0.48,2.48) 0.26
Indian [Chinese] -0.70 0.54 1.68 0.50 (0.17,1.43) 0.24
Duration of diabetes
≥5 years [<5 years] -0.78 0.37 4.33 0.46 (0.22,0.96) 0.04
hbA1c level 0.34 0.10 11.82 1.41 (1.16,1.72) <0.001
Treatment
Insulin [ohA] -0.26 0.45 0.34 0.77(0.32,1.85) 0.56
Diabetes complications
Proteinuria [no] 0.31 0.40 0.63 1.36 (0.64,2.91) 0.43
nephropathy [no] 2.19 0.68 10.23 8.91 (2.31,34.05) <0.001
retinopathy [no] -0.54 0.78 0.49 0.58 (0.13,2.66) 0.48
Ischaemic heart disease [no] 1.13 0.79 2.03 3.09 (0.65,14.64) 0.15
Cerebrovascular disease [no] 0.62 1.17 0.28 1.86 (0.19,18.47) 0.60
*ohA-oral hypoglycaemic agent
long-standing. In this study, those with diabetes for less 
than 5 years had higher odds to develop tuberculosis 
compared to those with longer duration. This is consistent 
with a retrospective population-based study in China that 
showed that mean duration of diabetes among those newly 
diagnosed with active tuberculosis was also less than 5 
years (Wu et al. 2016). This result could be because the 
glycaemic levels of those with newly diagnosed diabetes 
or those with shorter duration of diabetes may still not 
be very well controlled, thus, leading to low immunity 
which predisposes them to tuberculosis infection. This 
hypothesis is consistent with the findings of this study 
showing that an elevated hbA1c was associated with 1.4 
times odds of developing active tuberculosis. This was 
further supported by a study in hong Kong that showed 
an elevated hbA1c greater than 7% increased the risk 
of developing active tuberculosis by 3 times among 
diabetics compared to those with lower hbA1c levels 
(Leung et al. 2008). 
In this study, insulin use has not been associated 
with the development of tuberculosis, in concordance 
with the findings reported in a cohort study conducted in 
england (Pealing et al. 2015). however, this is in contrast 
with the studies conducted in Australia and Tanzania 
that found that insulin dependent diabetic patients had 
higher odds of developing active tuberculosis (Dobler 
et al. 2012; Swai et al. 1990). This could be due to the 
cases studied being among those with shorter duration of 
diabetes and younger age group. These groups of people 
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are usually least likely to be on insulin, tending to be on 
oral hypoglycaemic agent medication instead. 
Another important result found in this study was 
that nephropathy increased the odds of developing 
tuberculosis by almost 9 times compared to those without 
nephropathy. This result is consistent to a systematic 
review that showed the risk of developing active TB 
among patients who had end stage renal failure was 3.6 
times higher risk compared to their counterparts (Al-
Efraij et al. 2015). Similar findings were also observed in 
a study conducted in India which showed that patients 
with end stage renal failure, either with or without 
dialysis, were more likely to develop active tuberculosis 
(Abdelreheem et al. 2014). A study in england had shown 
that the time recorded from the diagnosis of end stage 
renal failure to the development of active tuberculosis 
was about 12 months (ostermann et al. 2016). however, 
this study had insufficient data to stage the chronic kidney 
diseases (CKD) and none of patients with nephropathy 
were on dialysis. nonetheless, this study managed 
to show that it is important to monitor patients with 
nephropathy for tuberculosis. This is in agreement with 
the recommendation by the British Thoracic Society to 
screen patient for tuberculosis using tuberculin skin test 
in those with chronic kidney disease, regardless of stage 
(Milburn et al. 2010). however, other factors like diabetic 
treatment regime, proteinuria, retinopathy, ischemic heart 
disease, cerebrovascular disease, gender, and ethnicity 
were found not to be associated with active tuberculosis 
among diabetic patients. 
This study found age plays an important role in 
the epidemiology of tuberculosis. Younger patients had 
a higher risk of contracting tuberculosis compared to an 
older age group. The risk of contracting tuberculosis was 
reduced by 4% with every one-year increment of age. 
This is consistent with the local data showing that TB 
notification age peaks between 20 and 60 years, followed 
by a decline after 60 years of age (Swarna nantha 2012). 
Similarly, a study conducted in Cape Town, South 
Africa on age-structured transmission of TB showed that 
the incidence of TB peaks between the ages of 30 and 
50 in the hIV negative population (Blaser et al. 2016). 
however, this is in contrast to the common understanding 
that immunity declines with increasing age and thus 
increases the risk of infection (Shaw et al. 2013). It is not 
well understood why tuberculosis incidence rates decline 
with increasing age; perhaps patients above 60 years 
may have acquired the immunological protective effect 
from a previous tuberculosis infection. More research is 
needed to understand this relationship.
The strength of this study was that the data were 
obtained systematically from the national registries, 
which may eliminate selection biases. however, there are 
a few limitations as well. As this study used retrospective 
data, the actual causal relationship between diabetes 
and tuberculosis could not be determined. A cohort 
study would be a better design to investigate associated 
factors by choosing subjects with a similar background 
and clinical characteristics and follow them up over a 
period. In this study, confounding factors such as level of 
education, occupation and household income were not 
available for inclusion in the analysis. The current study 
was also limited by the lack of information to calculate 
the estimated glomerular filtration rate, and thus this 
study could not stage the chronic kidney disease. It would 
be useful to assess the stages of chronic kidney disease 
and investigate the susceptible stages associated with the 
presence of tuberculosis. however, this study may guide 
the clinicians in tuberculosis screening among diabetics.
ConCLuSIon 
This research extends our knowledge on factors that 
increased the likelihood of having tuberculosis among 
type 2 diabetes patients. Clinical factors significantly 
associated with tuberculosis infection included duration 
of diabetes, hbA1c level and nephropathy, while age 
was the only demographic factor significantly associated 
with the infection. Patients with nephropathy who were 
not on dialysis had a nine times higher risk of developing 
tuberculosis. 
Therefore, this study would like to suggest for 
the routine screening for tuberculosis among patients 
with diabetes, physicians should consider the duration 
of disease, glycemic control, presence of nephropathy, 
and age. Screening for tuberculosis in specific patient 
populations may be more practical and cost-effective, but 
further studies are required to examine the effectiveness 
of this targeted screening program.
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